CASP8 has been associated with HRAS mutations [31] and seems to define a subgroup of HPV-negative oral cancers recently identified by the presence of activating mutations in HRAS, inactivating CAPS8 mutations and wild type TP53 [33]. Here, HRAS is linked to lip and oral cavity carcinoma.